{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:03:23Z","timestamp":1787623403172,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100011696","name":"Shahed University","doi-asserted-by":"publisher","award":["IR.SHAHED.REC.1402.102"],"award-info":[{"award-number":["IR.SHAHED.REC.1402.102"]}],"id":[{"id":"10.13039\/501100011696","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00210-026-05261-5","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:12:02Z","timestamp":1777432322000},"page":"15503-15519","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Resveratrol-mediated disruption of the CD73\u2013adenosine\u2013A2AR\/A2BR axis induces antitumor activity in colon cancer cells"],"prefix":"10.1007","volume":"399","author":[{"given":"Maryam","family":"Talebi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Dehghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramazan","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"5261_CR1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.14744\/ejmo.2024.20665","volume":"8","author":"E Alves","year":"2024","unstructured":"Alves E, Bannimath G, Prabhakaran P, Beeraka NM (2024) The FN3K-Nrf2 axis: a novel therapeutic target in cancer metabolism. Eurasian J Med Oncol 8:383\u2013393","journal-title":"Eurasian J Med Oncol"},{"key":"5261_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1225530","volume":"14","author":"A Brockmueller","year":"2023","unstructured":"Brockmueller A, Buhrmann C, Shayan P, Shakibaei M (2023) Resveratrol induces apoptosis by modulating the reciprocal crosstalk between p53 and Sirt-1 in the CRC tumor microenvironment. Front Immunol 14:1225530","journal-title":"Front Immunol"},{"key":"5261_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28155761","author":"M \u0106wikli\u0144ska-Jurkowska","year":"2023","unstructured":"\u0106wikli\u0144ska-Jurkowska M, Wiese-Szadkowska M, Janciauskiene S, Paprocka R (2023) Disparities in cisplatin-induced cytotoxicity-a meta-analysis of selected cancer cell lines. Molecules. https:\/\/doi.org\/10.3390\/molecules28155761","journal-title":"Molecules"},{"key":"5261_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111472","author":"C Dillard","year":"2021","unstructured":"Dillard C, Borde C, Mohammad A, Puchois V, Jourdren L, Larsen AK, Sabbah M, Mar\u00e9chal V, Escargueil AE, Pramil E (2021) Expression pattern of purinergic signaling components in colorectal cancer cells and differential cellular outcomes induced by extracellular ATP and adenosine. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms222111472","journal-title":"Int J Mol Sci"},{"key":"5261_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.cbi.2017.12.029","volume":"281","author":"A Flores-P\u00e9rez","year":"2018","unstructured":"Flores-P\u00e9rez A, Elizondo G (2018) Apoptosis induction and inhibition of HeLa cell proliferation by alpha-naphthoflavone and resveratrol are aryl hydrocarbon receptor-independent. Chem Biol Interact 281:98\u2013105","journal-title":"Chem Biol Interact"},{"key":"5261_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3892\/ijo.2025.5813","volume":"67","author":"D Fu","year":"2025","unstructured":"Fu D, Fu H, Wang Y, Yang K, Nie B, Lu X (2025) Therapeutic potentials of plant-based antioxidants on colorectal cancer: challenges and perspectives. Int J Oncol 67:107","journal-title":"Int J Oncol"},{"key":"5261_CR7","doi-asserted-by":"crossref","unstructured":"Fu B, Liu W, Wang Y, Li G, Wang Y, Huang X, Shi H, Qin C (2024) Design and synthesis of thiourea-conjugating organic arsenic D-glucose with anticancer activities. Molecules (Basel, Switzerland) 29","DOI":"10.21203\/rs.3.rs-4011963\/v1"},{"key":"5261_CR8","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.ejca.2004.12.020","volume":"41","author":"S Fulda","year":"2005","unstructured":"Fulda S, Debatin K-M (2005) Resveratrol-mediated sensitisation to TRAIL-induced apoptosis depends on death receptor and mitochondrial signalling. Eur J Cancer 41:786\u2013798","journal-title":"Eur J Cancer"},{"key":"5261_CR9","first-page":"577","volume":"22","author":"SP Garc\u00eda-Zepeda","year":"2013","unstructured":"Garc\u00eda-Zepeda SP, Garc\u00eda-Villa E, D\u00edaz-Ch\u00e1vez J, Hern\u00e1ndez-Pando R, Gariglio P (2013) Resveratrol induces cell death in cervical cancer cells through apoptosis and autophagy. Eur J Cancer Prev Off J Eur Cancer Prev Organ (ECP) 22:577\u2013584","journal-title":"Eur J Cancer Prev Off J Eur Cancer Prev Organ (ECP)"},{"key":"5261_CR10","doi-asserted-by":"publisher","first-page":"8738","DOI":"10.18632\/oncotarget.14434","volume":"8","author":"Y Inoue","year":"2017","unstructured":"Inoue Y, Yoshimura K, Kurabe N, Kahyo T, Kawase A, Tanahashi M, Ogawa H, Inui N, Funai K, Shinmura K, Niwa H, Suda T, Sugimura H (2017) Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer. Oncotarget 8:8738\u20138751","journal-title":"Oncotarget"},{"key":"5261_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.110170","volume":"368","author":"MR Islam","year":"2022","unstructured":"Islam MR, Akash S, Rahman MM, Nowrin FT, Akter T, Shohag S, Rauf A, Aljohani ASM, Simal-Gandara J (2022) Colon cancer and colorectal cancer: prevention and treatment by potential natural products. Chem Biol Interact 368:110170","journal-title":"Chem Biol Interact"},{"key":"5261_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232213689","author":"JY Jang","year":"2022","unstructured":"Jang JY, Im E, Kim ND (2022) Mechanism of resveratrol-induced programmed cell death and new drug discovery against cancer: a review. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232213689","journal-title":"Int J Mol Sci"},{"key":"5261_CR13","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3892\/or.2015.4384","volume":"35","author":"X Jing","year":"2016","unstructured":"Jing X, Cheng W, Wang S, Li P, He L (2016) Resveratrol induces cell cycle arrest in human gastric cancer MGC803 cells via the PTEN-regulated PI3K\/Akt signaling pathway. Oncol Rep 35:472\u2013478","journal-title":"Oncol Rep"},{"key":"5261_CR14","first-page":"7397","volume":"15","author":"A Koraneekit","year":"2018","unstructured":"Koraneekit A, Limpaiboon T, Sangka A, Boonsiri P, Daduang S, Daduang J (2018) Synergistic effects of cisplatin-caffeic acid induces apoptosis in human cervical cancer cells via the mitochondrial pathways. Oncol Lett 15:7397\u20137402","journal-title":"Oncol Lett"},{"key":"5261_CR15","first-page":"630","volume":"43","author":"D Li","year":"2019","unstructured":"Li D, Wang G, Jin G, Yao K, Zhao Z, Bie L, Guo Y, Li N, Deng W, Chen X (2019) Resveratrol suppresses colon cancer growth by targeting the AKT\/STAT3 signaling pathway. Int J Mol Med 43:630\u2013640","journal-title":"Int J Mol Med"},{"key":"5261_CR16","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s12033-024-01167-w","volume":"67","author":"H Liu","year":"2025","unstructured":"Liu H, Zhang L, Hao L, Fan D (2025) Resveratrol inhibits colorectal cancer cell tumor property by activating the miR-769-5p\/MSI1 pathway. Mol Biotechnol 67:1893\u20131907","journal-title":"Mol Biotechnol"},{"key":"5261_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1007801","volume":"13","author":"S Mu\u00f1oz-L\u00f3pez","year":"2022","unstructured":"Mu\u00f1oz-L\u00f3pez S, S\u00e1nchez-Melgar A, Mart\u00edn M, Albasanz JL (2022) Resveratrol enhances A(1) and hinders A(2A) adenosine receptors signaling in both HeLa and SH-SY5Y cells: potential mechanism of its antitumoral action. Front Endocrinol 13:1007801","journal-title":"Front Endocrinol"},{"key":"5261_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.intimp.2014.02.011","volume":"20","author":"O Naamani","year":"2014","unstructured":"Naamani O, Chaimovitz C, Douvdevani A (2014) Pharmacological preconditioning with adenosine A(1) receptor agonist suppresses cellular immune response by an A(2A) receptor dependent mechanism. Int Immunopharmacol 20:205\u2013212","journal-title":"Int Immunopharmacol"},{"key":"5261_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01038","volume":"10","author":"T Qin","year":"2020","unstructured":"Qin T, Cheng L, Xiao Y, Qian W, Li J, Wu Z, Wang Z, Xu Q, Duan W, Wong L, Wu E, Ma Q, Ma J (2020) NAF-1 inhibition by resveratrol suppresses cancer stem cell-like properties and the invasion of pancreatic cancer. Front Oncol 10:1038","journal-title":"Front Oncol"},{"key":"5261_CR20","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1080\/10408398.2016.1263597","volume":"58","author":"A Rauf","year":"2018","unstructured":"Rauf A, Imran M, Butt MS, Nadeem M, Peters DG, Mubarak MS (2018) Resveratrol as an anti-cancer agent: a review. Crit Rev Food Sci Nutr 58:1428\u20131447","journal-title":"Crit Rev Food Sci Nutr"},{"key":"5261_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2021.05.001","volume":"515","author":"B Ren","year":"2021","unstructured":"Ren B, Kwah MX, Liu C, Ma Z, Shanmugam MK, Ding L, Xiang X, Ho PC, Wang L, Ong PS, Goh BC (2021) Resveratrol for cancer therapy: challenges and future perspectives. Cancer Lett 515:63\u201372","journal-title":"Cancer Lett"},{"key":"5261_CR22","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.urolonc.2011.10.009","volume":"31","author":"L Rockenbach","year":"2013","unstructured":"Rockenbach L, Bavaresco L, Fernandes Farias P, Cappellari AR, Barrios CH, Bueno Morrone F, Oliveira Battastini AM (2013) Alterations in the extracellular catabolism of nucleotides are involved in the antiproliferative effect of quercetin in human bladder cancer T24 cells. Urol Oncol 31:1204\u20131211","journal-title":"Urol Oncol"},{"key":"5261_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.freeradbiomed.2019.03.019","volume":"135","author":"A Sanchez-Melgar","year":"2019","unstructured":"Sanchez-Melgar A, Albasanz JL, Guix\u00e0-Gonz\u00e1lez R, Saleh N, Selent J, Mart\u00edn M (2019) The antioxidant resveratrol acts as a non-selective adenosine receptor agonist. Free Radic Biol Med 135:261\u2013273","journal-title":"Free Radic Biol Med"},{"key":"5261_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.702817","volume":"15","author":"A S\u00e1nchez-Melgar","year":"2021","unstructured":"S\u00e1nchez-Melgar A, Mu\u00f1oz-L\u00f3pez S, Albasanz JL, Mart\u00edn M (2021) Antitumoral action of resveratrol through adenosinergic signaling in C6 glioma cells. Front Neurosci 15:702817","journal-title":"Front Neurosci"},{"key":"5261_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232565","volume":"15","author":"A Suarez-Arnedo","year":"2020","unstructured":"Suarez-Arnedo A, Figueroa FT, Clavijo C, Arbel\u00e1ez P, Cruz JC, Mu\u00f1oz-Camargo C (2020) An image J plugin for the high throughput image analysis of in vitro scratch wound healing assays. PLoS ONE 15:e0232565","journal-title":"PLoS ONE"},{"key":"5261_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.837230","volume":"13","author":"C Sun","year":"2022","unstructured":"Sun C, Wang B, Hao S (2022) Adenosine-A2A receptor pathway in cancer immunotherapy. Front Immunol 13:837230","journal-title":"Front Immunol"},{"key":"5261_CR27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3892\/ijo.2017.3859","volume":"50","author":"M Takashina","year":"2017","unstructured":"Takashina M, Inoue S, Tomihara K, Tomita K, Hattori K, Zhao QL, Suzuki T, Noguchi M, Ohashi W, Hattori Y (2017) Different effect of resveratrol to induction of apoptosis depending on the type of human cancer cells. Int J Oncol 50:787\u2013797","journal-title":"Int J Oncol"},{"key":"5261_CR28","doi-asserted-by":"crossref","unstructured":"Tong G, Peng T, Chen Y, Sha L, Dai H, Xiang Y, Zou Z, He H, Wang S (2022) Effects of GLP-1 receptor agonists on biological behavior of colorectal cancer cells by regulating PI3K\/AKT\/mTOR signaling pathway. Front Pharmacol 13","DOI":"10.3389\/fphar.2022.901559"},{"key":"5261_CR29","doi-asserted-by":"crossref","unstructured":"Vervandier-Fasseur D, Latruffe N (2019) The potential use of resveratrol for cancer prevention. Molecules (Basel, Switzerland) 24","DOI":"10.3390\/molecules24244506"},{"key":"5261_CR30","doi-asserted-by":"publisher","DOI":"10.1177\/15330338221150318","volume":"22","author":"H Wang","year":"2023","unstructured":"Wang H, Tan F, Xu Y, Ma Y, Li Y, Xiao H (2023) Adenosine receptor A2B antagonist inhibits the metastasis of gastric cancer cells and enhances the efficacy of cisplatin. Technol Cancer Res Treat 22:15330338221150318","journal-title":"Technol Cancer Res Treat"},{"key":"5261_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01733-x","volume":"22","author":"C Xia","year":"2023","unstructured":"Xia C, Yin S, To KKW, Fu L (2023) CD39\/CD73\/A2AR pathway and cancer immunotherapy. Mol Cancer 22:44","journal-title":"Mol Cancer"},{"key":"5261_CR32","first-page":"1569","volume":"17","author":"Z Yang","year":"2019","unstructured":"Yang Z, Xie Q, Chen Z, Ni H, Xia L, Zhao Q, Chen Z, Chen P (2019) Resveratrol suppresses the invasion and migration of human gastric cancer cells via inhibition of MALAT1-mediated epithelial-to-mesenchymal transition. Exp Ther Med 17:1569\u20131578","journal-title":"Exp Ther Med"},{"key":"5261_CR33","doi-asserted-by":"crossref","unstructured":"Yang H, Li Q, Chen X, Weng M, Huang Y, Chen Q, Liu X, Huang H, Feng Y, Zhou H, Zhang M, Pei W, Li X, Fu Q, Zhu L, Wang Y, Kong X, Lv K, Zhang Y, Sun Y, Ma M (2024) Targeting SOX13 inhibits assembly of respiratory chain supercomplexes to overcome ferroptosis resistance in gastric cancer. Nat Commun 15","DOI":"10.1038\/s41467-024-48307-z"},{"key":"5261_CR34","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2020.12032","volume":"20","author":"M Ye","year":"2020","unstructured":"Ye M, Tian H, Lin S, Mo J, Li Z, Chen X, Liu J (2020) Resveratrol inhibits proliferation and promotes apoptosis via the androgen receptor splicing variant 7 and PI3K\/AKT signaling pathway in LNCaP prostate cancer cells. Oncol Lett 20:169","journal-title":"Oncol Lett"},{"key":"5261_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.826","volume":"11","author":"H Ye","year":"2023","unstructured":"Ye H, Zhao J, Xu X, Zhang D, Shen H, Wang S (2023) Role of adenosine A2a receptor in cancers and autoimmune diseases. Immun Inflamm Dis 11:e826","journal-title":"Immun Inflamm Dis"},{"key":"5261_CR36","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.7314\/APJCP.2013.14.3.1703","volume":"14","author":"HT Yin","year":"2013","unstructured":"Yin HT, Tian QZ, Guan L, Zhou Y, Huang XE, Zhang H (2013) In vitro and in vivo evaluation of the antitumor efficiency of resveratrol against lung cancer. Asian Pac J Cancer Prev 14:1703\u20131706","journal-title":"Asian Pac J Cancer Prev"},{"key":"5261_CR37","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ccell.2016.06.025","volume":"30","author":"A Young","year":"2016","unstructured":"Young A, Ngiow SF, Barkauskas DS, Sult E, Hay C, Blake SJ, Huang Q, Liu J, Takeda K, Teng MWL, Sachsenmeier K, Smyth MJ (2016) Co-inhibition of CD73 and A2AR adenosine signaling improves anti-tumor immune responses. Cancer Cell 30:391\u2013403","journal-title":"Cancer Cell"},{"key":"5261_CR38","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/s41419-018-1178-5","volume":"9","author":"Z Zheng","year":"2018","unstructured":"Zheng Z, Hu H, Tong Y, Hu Z, Cao S, Shan C, Lin W, Yin Y, Li Z (2018) MiR-27b regulates podocyte survival through targeting adenosine receptor 2B in podocytes from non-human primate. Cell Death Dis 9:1133","journal-title":"Cell Death Dis"},{"key":"5261_CR39","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s10585-007-9081-y","volume":"24","author":"X Zhi","year":"2007","unstructured":"Zhi X, Chen S, Zhou P, Shao Z, Wang L, Ou Z, Yin L (2007) RNA interference of ecto-5\u2019-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion. Clin Exp Metastasis 24:439\u2013448","journal-title":"Clin Exp Metastasis"},{"key":"5261_CR40","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1111\/j.1349-7006.2010.01733.x","volume":"101","author":"X Zhi","year":"2010","unstructured":"Zhi X, Wang Y, Zhou X, Yu J, Jian R, Tang S, Yin L, Zhou P (2010) RNAi-mediated CD73 suppression induces apoptosis and cell-cycle arrest in human breast cancer cells. Cancer Sci 101:2561\u20132569","journal-title":"Cancer Sci"},{"key":"5261_CR41","doi-asserted-by":"publisher","first-page":"426","DOI":"10.4161\/cbt.6.3.3762","volume":"6","author":"P Zhou","year":"2007","unstructured":"Zhou P, Zhi X, Zhou T, Chen S, Li X, Wang L, Yin L, Shao Z, Ou Z (2007a) Overexpression of ecto-5\u2019-nucleotidase (CD73) promotes T-47D human breast cancer cells invasion and adhesion to extracellular matrix. Cancer Biol Ther 6:426\u2013431","journal-title":"Cancer Biol Ther"},{"key":"5261_CR42","first-page":"1341","volume":"17","author":"X Zhou","year":"2007","unstructured":"Zhou X, Zhi X, Zhou P, Chen S, Zhao F, Shao Z, Ou Z, Yin L (2007b) Effects of ecto-5\u2019-nucleotidase on human breast cancer cell growth in vitro and in vivo. Oncol Rep 17:1341\u20131346","journal-title":"Oncol Rep"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05261-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05261-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05261-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:04:42Z","timestamp":1784775882000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05261-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5261"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05261-5","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"29 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We clarify that we have not used any AI tools or technologies to generate the original content of this manuscript. However, ChatGPT\u20114 was used to improve the language quality and correct possible grammatical errors in the manuscript.","order":1,"name":"Ethics","label":"Declaration of generative AI","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}